6 Matching Annotations
  1. Feb 2026
  2. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    Navitoclax, a Bcl-2/xL inhibitor, and YM155, a survivin inhibitor, in combination with carboplatin, effectively inhibit ovarian cancer tumor growth
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC12316570/
  3. Jun 2025
  4. www.nature.com www.nature.com
    Radiation-induced amphiregulin drives tumour metastasis
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    nature.com/articles/s41586-025-08994-0
  5. Sep 2024
  6. pubs.acs.org pubs.acs.org
    Identification of CDK4/6 Inhibitors as Small Molecule NLRP3 Inflammasome Activators that Facilitate IL-1β Secretion and T Cell Adjuvanticity
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pubs.acs.org/doi/full/10.1021/acs.jmedchem.4c00516
  7. Dec 2023
  8. www.nature.com www.nature.com
    ERα/PR crosstalk is altered in the context of the ERα Y537S mutation and contributes to endocrine therapy-resistant tumor proliferation
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    nature.com/articles/s41523-023-00601-7
  9. Aug 2023
  10. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Evaluating steroid hormone receptor interactions using the live-cell NanoBRET proximity assay
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC10402027/
  11. Mar 2023
  12. pubs.acs.org pubs.acs.org
    Discovery of New States of Immunomodulation for Vaccine Adjuvants via High Throughput Screening: Expanding Innate Responses to PRRs
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pubs.acs.org/doi/full/10.1021/acscentsci.2c01351